Yonger Xue

1.5k total citations · 2 hit papers
25 papers, 954 citations indexed

About

Yonger Xue is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Yonger Xue has authored 25 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Immunology and 4 papers in Oncology. Recurrent topics in Yonger Xue's work include RNA Interference and Gene Delivery (14 papers), Immunotherapy and Immune Responses (8 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Yonger Xue is often cited by papers focused on RNA Interference and Gene Delivery (14 papers), Immunotherapy and Immune Responses (8 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Yonger Xue collaborates with scholars based in United States, China and Singapore. Yonger Xue's co-authors include Yizhou Dong, Shi Du, Jinyue Yan, Xucheng Hou, Wenqing Li, Yichen Zhong, David W. McComb, Binbin Deng, Pengxuan Zhao and Diana D. Kang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Chemical Society Reviews.

In The Last Decade

Yonger Xue

23 papers receiving 943 citations

Hit Papers

Redox-responsive polymer ... 2024 2026 2024 2024 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yonger Xue United States 15 573 250 235 167 137 25 954
María L. Guevara Peru 12 604 1.1× 307 1.2× 198 0.8× 129 0.8× 186 1.4× 36 1.0k
Marshall S. Padilla United States 16 616 1.1× 145 0.6× 152 0.6× 151 0.9× 106 0.8× 27 931
Diana D. Kang United States 15 540 0.9× 281 1.1× 162 0.7× 89 0.5× 154 1.1× 25 853
Tongren Yang China 13 835 1.5× 188 0.8× 198 0.8× 90 0.5× 72 0.5× 18 1.1k
Ranit Kedmi Israel 9 1.1k 1.9× 282 1.1× 173 0.7× 185 1.1× 135 1.0× 12 1.3k
Eilam Yeini Israel 14 377 0.7× 246 1.0× 413 1.8× 166 1.0× 276 2.0× 27 1.1k
Qingfeng Chen Singapore 14 395 0.7× 198 0.8× 179 0.8× 76 0.5× 152 1.1× 20 825
Yi Lin China 16 615 1.1× 227 0.9× 289 1.2× 174 1.0× 121 0.9× 32 1.1k
Jilian R. Melamed United States 14 638 1.1× 121 0.5× 175 0.7× 155 0.9× 60 0.4× 22 884

Countries citing papers authored by Yonger Xue

Since Specialization
Citations

This map shows the geographic impact of Yonger Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonger Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonger Xue more than expected).

Fields of papers citing papers by Yonger Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yonger Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonger Xue. The network helps show where Yonger Xue may publish in the future.

Co-authorship network of co-authors of Yonger Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Yonger Xue. A scholar is included among the top collaborators of Yonger Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yonger Xue. Yonger Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yuebao, Kaiyuan Guo, Shi Du, et al.. (2025). Aminophosphonate-Derived lipid nanoparticles enable circular RNA delivery for functional recovery after spinal cord injury. Materials Today. 91. 148–157.
2.
Cao, Dinglingge, Xucheng Hou, Chang Wang, et al.. (2025). Lipid nanoparticles for mRNA delivery in brain via systemic administration. Science Advances. 11(33). eadw0730–eadw0730. 2 indexed citations
4.
Wang, Chang, Siyu Wang, Yonger Xue, et al.. (2024). Intravenous administration of blood–brain barrier-crossing conjugates facilitate biomacromolecule transport into central nervous system. Nature Biotechnology. 43(11). 1783–1789. 16 indexed citations
5.
Kang, Diana D., Xucheng Hou, Leiming Wang, et al.. (2024). Engineering LNPs with polysarcosine lipids for mRNA delivery. Bioactive Materials. 37. 86–93. 36 indexed citations
6.
Wang, Siyu, Yuebao Zhang, Yichen Zhong, et al.. (2024). Accelerating diabetic wound healing by ROS-scavenging lipid nanoparticle–mRNA formulation. Proceedings of the National Academy of Sciences. 121(22). e2322935121–e2322935121. 30 indexed citations
7.
Xue, Yonger, Yuebao Zhang, Yichen Zhong, et al.. (2024). LNP-RNA-engineered adipose stem cells for accelerated diabetic wound healing. Nature Communications. 15(1). 739–739. 46 indexed citations breakdown →
8.
Xu, Xiaoxuan, Xin Chen, Yonger Xue, et al.. (2024). Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy. Nature Communications. 15(1). 1118–1118. 48 indexed citations breakdown →
9.
Yan, Jinyue, Diana D. Kang, Chang Wang, et al.. (2024). LPA1 antagonist-derived LNPs deliver A20 mRNA and promote anti-fibrotic activities. Nano Research. 17(10). 9095–9102. 1 indexed citations
10.
Du, Shi, Wenqing Li, Yuebao Zhang, et al.. (2023). Cholesterol‐Amino‐Phosphate (CAP) Derived Lipid Nanoparticles for Delivery of Self‐Amplifying RNA and Restoration of Spermatogenesis in Infertile Mice. Advanced Science. 10(11). e2300188–e2300188. 36 indexed citations
12.
Chen, Shuying, Xiangang Huang, Yonger Xue, et al.. (2023). Nanotechnology-based mRNA vaccines. Nature Reviews Methods Primers. 3(1). 98 indexed citations
13.
Zhang, Yuebao, Xucheng Hou, Shi Du, et al.. (2023). Close the cancer–immunity cycle by integrating lipid nanoparticle–mRNA formulations and dendritic cell therapy. Nature Nanotechnology. 18(11). 1364–1374. 66 indexed citations
14.
Du, Shi, et al.. (2023). Adoptive cell therapy for cancer treatment. SHILAP Revista de lepidopterología. 3(4). 20210058–20210058. 62 indexed citations
15.
Zhang, Yuebao, Jinyue Yan, Xucheng Hou, et al.. (2023). STING Agonist-Derived LNP-mRNA Vaccine Enhances Protective Immunity Against SARS-CoV-2. Nano Letters. 23(7). 2593–2600. 59 indexed citations
16.
Xue, Yonger, et al.. (2022). Recent advances in biomaterial-boosted adoptive cell therapy. Chemical Society Reviews. 51(5). 1766–1794. 52 indexed citations
17.
Zhao, Weiyu, Chunxi Zeng, Jinyue Yan, et al.. (2021). Construction of Messenger RNA (mRNA) Probes Delivered By Lipid Nanoparticles to Visualize Intracellular Protein Expression and Localization at Organelles. Advanced Materials. 33(45). e2103131–e2103131. 9 indexed citations
18.
Xie, Jinbing, Daniel Gonzalez‐Carter, Theofilus A. Tockary, et al.. (2020). Dual-Sensitive Nanomicelles Enhancing Systemic Delivery of Therapeutically Active Antibodies Specifically into the Brain. ACS Nano. 14(6). 6729–6742. 88 indexed citations
19.
Xue, Yonger, Jia Feng, Yilei Liu, et al.. (2020). A Synthetic Carrier of Nucleic Acids Structured as a Neutral Phospholipid Envelope Tightly Assembled on Polyplex Surface. Advanced Healthcare Materials. 9(6). e1901705–e1901705. 10 indexed citations
20.
Zhao, Pengxuan, Xucheng Hou, Jinyue Yan, et al.. (2020). Long-term storage of lipid-like nanoparticles for mRNA delivery. Bioactive Materials. 5(2). 358–363. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026